Sylvie Luce
Impact in
- Geriatrics and Gerontology top 5%
- Frailty in Older Adults
- Oncology top 5%
- HER2/EGFR in Cancer Research
- PARP inhibition in cancer therapy
- Cancer Treatment and Pharmacology
Papers in
-
- Frailty in Older Adults 7
- Genetics 4
- Glioma Diagnosis and Treatment 3
- Co-authors
- Lore Decoster (2 shared papers)Thierry Pepersack (2 shared papers)Sandra De Breucker (2 shared papers)Bernard Kennès (1 shared paper)Cindy Kenis (1 shared paper)Hans P. M. W. Wildiers (1 shared paper)Ruud Van Rijswijk (1 shared paper)Guy Jérusalem (1 shared paper)
- Journals
- Journal of Geriatric Oncology (4 papers)The Lancet Healthy Longevity (1 paper)Neuro-Oncology (1 paper)Journal of Neurology (1 paper)Cancers (1 paper)
- Partner nations
- BelgiumItalyNetherlands
In The Last Decade
Sylvie Luce
18 papers receiving 938 citations
Sylvie Luce's Hit Papers
Peers
Comparison fields: 5 of 63
- Geriatrics and Gerontology 83
- Oncology 499
- Cancer Research 263
- Pulmonary and Respiratory Medicine 236
- Genetics 68
Countries citing papers authored by Sylvie Luce
This map shows the geographic impact of Sylvie Luce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Luce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Luce more than expected).
Fields of papers citing papers by Sylvie Luce
This network shows the impact of papers produced by Sylvie Luce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Luce. The network helps show where Sylvie Luce may publish in the future.
Co-authors
The 25 scholars most cited alongside Sylvie Luce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Hit paper breakdown → | 2017 | 461 |
| 2 | Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer Hit paper breakdown → | 2022 | 321 |
| 3 | 2015 | 45 | |
| 4 | 2016 | 24 | |
| 5 | 2019 | 24 | |
| 6 | 2020 | 19 | |
| 7 | 2015 | 12 | |
| 8 | 2017 | 11 | |
| 9 | 2023 | 11 | |
| 10 | 2019 | 9 | |
| 11 | 2022 | 4 | |
| 12 | Chemotherapy for malignant mesothelioma: a quantitative and qualitative overview of the literature | 1999 | 4 |
| 13 | 2023 | 3 | |
| 14 | 2016 | 2 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2018 | 2 | |
| 18 | Etoposide oral administré de manière prolongé: un traitement partiellement non cross-résistant avec les dérivés Taxanes dans le cancer de l’ovaire | 1993 | 1 |
About Sylvie Luce
Sylvie Luce is a scholar working on Geriatrics and Gerontology, Genetics, Oncology, Pulmonary and Respiratory Medicine and Neurology, having authored 18 papers that have together received 957 indexed citations. Recurring topics across this work include Frailty in Older Adults (7 papers), Glioma Diagnosis and Treatment (3 papers), Brain Metastases and Treatment (2 papers), Inflammatory Biomarkers in Disease Prognosis (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Tracheal and airway disorders (1 paper), Lung Cancer Research Studies (1 paper) and Adipokines, Inflammation, and Metabolic Diseases (1 paper). The work is most often cited by research in Geriatrics and Gerontology (83 citations), Oncology (499 citations), Cancer Research (263 citations), Pulmonary and Respiratory Medicine (236 citations) and Genetics (68 citations). Sylvie Luce has collaborated with scholars based in Belgium, Italy and Netherlands. Frequent co-authors include Lore Decoster, Thierry Pepersack, Sandra De Breucker, Bernard Kennès, Cindy Kenis, Hans P. M. W. Wildiers, Ruud Van Rijswijk, Guy Jérusalem, Christine Langenaeken and Johan Flamaing. Their work appears in journals such as Journal of Geriatric Oncology, The Lancet Healthy Longevity, Neuro-Oncology, Journal of Neurology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.